期刊文献+

胶原蛋白和弹力蛋白在血管组织工程中的应用 被引量:1

Application of collagen protein and elastin in blood vessel tissue-engineering
原文传递
导出
摘要 胶原蛋白和弹力蛋白是细胞外基质的2个非常重要的组成成分,不同的细胞外基质对于内皮细胞生长和组织再生都有很重要的作用。胶原蛋白是构成细胞外基质的骨架结构,用不同的方法将胶原与不同的物质聚合可以得到不同机械性能和生物特性的血管支架。胶原蛋白作为一种促凝剂,利用一定的方法尽量避免组织血管中胶原蛋白的暴露,可以防止工程血管的血栓形成,胶原交替联接和胶原袖套混合物可以加强支架替代物的机械强度;弹力蛋白是血管的重要的结构和起重要调节作用的基质蛋白,赋予血管壁弹性和良好生物学特性,用于支架和包被支架材料方面显示出巨大的应用潜能。 Collagen protein and elastin are two of the most important components of extracellular matrix.Different extracellular matrix play important role in endotheliocyte growth and tissue regeneration. Collagen protein as skeleton structures of extracellular matrix, combined with different materials and in different ways, results in intravascular stent substitutes with different manchnical strength and biological characteristics. Collagen as a coagulator that concealed by some methods can avoid thrombosis. The cross-linked collagen and the collagen oversleeve mixture used in scaffolds may strengthen the substitutes. Elastins are important structure of blood vessel and play important rote in maintaining the elasticity and bionomics of blood vessel, and thus have a tremendous application potential as scaffolds and coating scaffolds materials.
出处 《国际生物医学工程杂志》 CAS 北大核心 2009年第4期228-233,共6页 International Journal of Biomedical Engineering
基金 基金项目:国家863计划资助项目(2006AA03Z438)
关键词 组织工程血管 胶原蛋白 弹力蛋白 Tissue engineering blood vessel Collagen protein Elastin
  • 相关文献

参考文献21

  • 1Huynh T, Abraham G, Murray J, et al. Remodeling of an acellular collagen graft into a physiologically responsive neovessel[J]. Nat Biotechnol, 1999, 17(11): 1083-1086.
  • 2Wu HC, Wang TW, Kang PL, et al. Coculture of endothelial and smooth muscle cells on a collagen membrane in the development of a small-diameter vascular graft[J]. Biomaterials, 2007, 28(7): 1385- 1392.
  • 3He Wei, Yong T, Teo WE, et al. Fabrication and endothelialization of collagen-blended biodegradable polymer nanofibers: potential vascular graft for blood vessel tissue engineering[J]. Tissue Eng, 2005, 11(9-10): 1574-1588.
  • 4李贵华,王雷,贾三庆,赵林,姚道阔,丁荣晶,任文林.缬沙坦涂层支架置入兔腹主动脉对血管内膜胶原沉积及AT2受体表达的影响(英文)[J].中国组织工程研究与临床康复,2008,12(9):1761-1765. 被引量:1
  • 5Berglund JD, Mohseni MM, Nerem RM, et al. A biological hybrid model for collagen-based tissue engineered vascular constructs [J]. Biomaterials, 2003, 24(7): 1241-1254.
  • 6Seliktar D, Nerem RM, Galis ZS. Mechanical strain-stimulated remodeling of tissue-engineered blood vessel constructs[J]. Tissue Eng, 2003, 9(4): 657-666.
  • 7Elbjeirami WM, Yonter EO, Starcher BC, et al. Enhancing mechanical properties of tissue-engineered constructs via lysyl oxidase crosslinking activity[J]. J Biomed Mater Res A, 2003, 66(3): 513- 521.
  • 8Elder E, Chen Z, Ensley A, et al. Enhanced tissue strength in cryopreserved, collagen-based blood vessel constructs[J]. Transplant Proc, 2005, 37(10): 4625-4629.
  • 9Chart BP, So KF. Photochemical crosslinking improves the physicochemical properties of collagen scaffolds[J]. J Biomed Mater Res A, 2005, 75(3): 689-701.
  • 10Yin Yong-bai, Wise SG, Nosworthy NJ, et al. Covalent inunobilisation of tropoelastin on a plasma deposited interface for enhancement of endothelialisation on metal surfaces[J]. Biomaterials, 2009, 30(9): 1675-1681.

二级参考文献13

  • 1Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002;346(23): 1773-1780
  • 2Park S J, Shim WH, Ho DS, et al. A paclitaxel-eluting stent for the prevention of coronary restenosis. N Engl J Med 2003;348(16): 1537-1545
  • 3Lemos PA, Serruys PW, van Domburg RT, et al. Unrestricted utilization of sirolimus-eluting stents compared with conventional bare-metal stent implantation in the "real world": the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry. Circulation 2004;109(2):190-195
  • 4Virmani R, Guagliumi G, Farb A, et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation 2004;109(6):701-705
  • 5Edelman ER, Rogers C, Pathobiologic Responses to Stenting, Am J Cardiol 1998;81 (7A):4E-6E
  • 6Loot AE, Roks AJ, Henning RH, et al, Angiotensin (1-7) attenuates the development of heart failure after myocardial infarction in rats. Circulation 2002;105(13):1548-1550
  • 7Van Belle E, Meurice T, Tio FO, et al. ACE inhibition accelerates endothelial regrowth in vivo: a possible explanation for the benefit observed with ACE inhibitors foUowing arterial injury, Biochem Biophys Res Commun 1997;231(3):577-581
  • 8Peters S, Gotting B, Trummel M, et al. Valsartan for prevention of restenosis after stenting of type B2/C lesions: the Val-PREST Trial. J lnvas Cardiol 2001;13(2):93-97
  • 9Kim WH, Hong MK, Virmani R, et al. Histopathologic analysis of in-stent neointlmal regression in a porcine coronary model, Coron Artery Dis 2000;11(3):273-277
  • 10Farb A, Kolodgle FD, Hwang JY, et al, Extracellular Matrix Changes in Stented Human Coronary Arteries, Circulation 2004;110(8): 940-947

共引文献2

同被引文献30

  • 1徐红英,张晓燕.中药血竭研究进展[J].中医药学报,2011,39(4):101-103. 被引量:31
  • 2张自强,赵东旭,杨新林.羟脯氨酸的研究与开发[J].氨基酸和生物资源,2006,28(1):55-58. 被引量:39
  • 3史艳宇,徐惠波,纪凤兰,张伟,温富春,丁涛,张殿文,孙晓波.复方降压片对血瘀模型大鼠血液流变性的影响[J].中国实验方剂学杂志,2006,12(5):54-55. 被引量:3
  • 4徐应抒,李跃英,廖大忠,等.高血压病气滞血瘀证的微循环和血液流变学研究[J].泸州医学院学报,1986,9(3):188-191.
  • 5PARK B, YOU S, JUNG J, et al. Korean studies on blood stasis : an overview [ J ]. Evid Based Complement Alternat Med, 2015, 2015 : 316872.
  • 6XUTIAN S, CAO D, WOZN1AK J A, et al. Comprehension of the unique characteristics of traditional Chinese medicine [ J ]. Am J Chin Med, 2012, 40(2): 231.
  • 7TSANG I KY. Establishing the efficacy of traditional Chinese medicine [ J ]. Nat Clin Praet Rheumatol, 2007, 3 ( 2 ): 60.
  • 8HAN J, DATLA R, CHAN S, et al. Mass spectrometry-based technologies for high-throughput metabolomics [ J }. Bioanalysis, 2009, 1 ( 9 ): 1665.
  • 9LE MOYEC L, MILLE-HAMARD L, TRIBA MN, et al. NMR metabolomics for assessment of exercise effects with mouse biofluids [ J ]. Anal Bioanal Chem, 2012, 404 ( 2 ): 593.
  • 10YOSHIDA M, HATANO N, NISHIUMI S, et al. Diagnosis of gastroenterologieal diseases by metabolome analysis using gas chromatography-mass spectrometry [ J ]. J Gastroenterol, 2012, 47 (1):9.

引证文献1

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部